Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Massimo De Martinis, Fedra Ciccarelli, Maria Maddalena Sirufo & Lia Ginaldi. (2016) An overview of environmental risk factors in systemic sclerosis. Expert Review of Clinical Immunology 12:4, pages 465-478.
Read now
Read now
Saeideh Jafarinejad-Farsangi, Ali Farazmand, Mahdi Mahmoudi, Farhad Gharibdoost, Elham Karimizadeh, Farshid Noorbakhsh, Habibeh Faridani & Ahmad Reza Jamshidi. (2015) MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. Autoimmunity 48:6, pages 369-378.
Read now
Read now
Marie-Elise Truchetet, Nicolo C Brembilla, Elisa Montanari & Carlo Chizzolini. (2010) T-cell subsets in scleroderma patients. Expert Review of Dermatology 5:4, pages 403-415.
Read now
Read now
Alfonso J De LaVega & Chris T Derk. (2009) Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication. Expert Opinion on Investigational Drugs 18:1, pages 23-29.
Read now
Read now
Jennifer G. Walker, John Stirling, Dimitra Beroukas, Kencana Dharmapatni, David R. Haynes, Malcolm D. Smith, Michael J. Ahern & Peter J. Roberts‐Thomson. (2005) Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis. Pathology 37:3, pages 220-225.
Read now
Read now
Taio Naniwa, Shogo Banno, Nobuyuki Takahashi, Shinji Maeda, Yoshihito Hayami & Ryuzo Ueda. (2005) Normotensive scleroderma renal crisis with diffuse alveolar damage after corticosteroid therapy. Modern Rheumatology 15:2, pages 134-138.
Read now
Read now
Martine Clozel & Hashem Salloukh. (2005) Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan. Annals of Medicine 37:1, pages 2-12.
Read now
Read now
Articles from other publishers (84)
Joana Caetano, Luís Monteiro Rodrigues & José Delgado Alves. (2024) What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review. Autoimmunity Reviews 23:5, pages 103540.
Crossref
Crossref
Kazuhiro Komura, Koichi Yanaba, Jean-David Bouaziz, Ayumi Yoshizaki, Minoru Hasegawa, John Varga, Kazuhiko Takehara & Takashi Matsushita. (2024) Perspective to precision medicine in scleroderma. Frontiers in Immunology 14.
Crossref
Crossref
Danilo Menichelli, Vito Maria Cormaci, Silvia Marucci, Giovanni Franchino, Francesco Del Sole, Alessandro Capozza, Alessia Fallarino, Emanuele Valeriani, Francesco Violi, Pasquale Pignatelli & Daniele Pastori. (2023) Risk of venous thromboembolism in autoimmune diseases: A comprehensive review. Autoimmunity Reviews 22:11, pages 103447.
Crossref
Crossref
Carine Moezinia, Valerie Wong, James Watson, Lydia Nagib, Sandra Lopez Garces, Siyu Zhang, Bahja Ahmed Abdi, Florence Newton, David Abraham & Richard Stratton. (2023) Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis. Cells 12:20, pages 2490.
Crossref
Crossref
Shannon Teaw, Akash Gupta, Alyssa Williams, F. Perry Wilson, Brandon J. Sumpio, Bauer E. Sumpio & Monique Hinchcliff. (2023) Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon. Arthritis Research & Therapy 25:1.
Crossref
Crossref
Arianna Ferlito, Corrado Campochiaro, Alessandro Tomelleri, Lorenzo Dagna & Giacomo De Luca. (2022) Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies. Journal of Scleroderma and Related Disorders 7:3, pages 179-188.
Crossref
Crossref
Thuy Nguyen Thi Phuong, Trang Dao Thi, Ingrid E Lundberg & Binh Nguyen Huy. (2022) Atherosclerosis in Vietnamese patients with systemic sclerosis and its relationship to disease and traditional risk factors. Rheumatology Advances in Practice 6:2.
Crossref
Crossref
Rania M. Gamal, Hanan Sayed M. Abozaid, Mohmed Zidan, Mohamed Aboel-Kassem F. Abdelmegid, Mohmed Raouf Abdel-Razek, Sahar Abdel-Rahman Alsayed, Amr F. Mourad, Nashwa Mostafa A. Azoz, Lobna Abdel-Wahid Mohram & Daniel E. Furst. (2019) Study of MRI brain findings and carotid US features in systemic sclerosis patients, relationship with disease parameters. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Chan-Na Zhao, Peng Wang, Yan-Mei Mao, Yi-Lin Dan, Qian Wu, Xiao-Mei Li, De-Guang Wang, Callan Davis, Wenbiao Hu & Hai-Feng Pan. (2019) Potential role of melatonin in autoimmune diseases. Cytokine & Growth Factor Reviews 48, pages 1-10.
Crossref
Crossref
Dimitrios P. Bogdanos & Lazaros I. Sakkas. 2019. Mosaic of Autoimmunity. Mosaic of Autoimmunity
203
213
.
Cristina Panico & Gianluigi Condorelli. (2017) Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases. Clinical Reviews in Allergy & Immunology 55:3, pages 254-270.
Crossref
Crossref
Jamie King, David Abraham & Richard Stratton. (2018) Chemokines in systemic sclerosis. Immunology Letters 195, pages 68-75.
Crossref
Crossref
Lazaros I. Sakkas & Dimitrios P. Bogdanos. 2018. The Microbiome in Rheumatic Diseases and Infection. The Microbiome in Rheumatic Diseases and Infection
113
127
.
Sabina Oreska & Michal Tomcik. 2017. Systemic Sclerosis. Systemic Sclerosis.
Silvia Bellando Randone, Jacob George, Celestina Mazzotta, Serena Guiducci, Daniel E. Furst, Adi Mor & Marco Matucci Cerinic. (2016) Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview. Journal of Scleroderma and Related Disorders 2:1, pages 1-10.
Crossref
Crossref
Emily Hamburg-Shields, Peggy Myung & Shawn E. Cowper. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
577
600
.
Sara R. Schoenfeld, Hyon K. Choi, Eric C. Sayre & J. Antonio Aviña‐Zubieta. (2016) Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population‐Based Study. Arthritis Care & Research 68:2, pages 246-253.
Crossref
Crossref
Niloufar Kavian & Frédéric Batteux. (2015) Macro- and microvascular disease in systemic sclerosis. Vascular Pharmacology 71, pages 16-23.
Crossref
Crossref
Yuichiro Shirai & Masataka Kuwana. (2015) Reply. Arthritis & Rheumatology 67:5, pages 1409-1410.
Crossref
Crossref
Sonja Hetzer, Bettina Alexandra Buhren, Holger Schrumpf, Edwin Bölke, Stephan Meller, Kai Kammers, Peter Arne Gerber & Bernhard Homey. (2014) Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin. European Journal of Medical Research 19:1.
Crossref
Crossref
Joanna Nikitorowicz-Buniak, Xu Shiwen, Christopher P. Denton, David Abraham & Richard Stratton. (2014) Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9. Journal of Investigative Dermatology 134:11, pages 2693-2702.
Crossref
Crossref
Allison L Mathes, Romy B Christmann, Giuseppina Stifano, Alsya J Affandi, Timothy R D J Radstake, G Alessandra Farina, Cristina Padilla, Sarah McLaughlin & Robert Lafyatis. (2014) Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. Annals of the Rheumatic Diseases 73:10, pages 1864-1872.
Crossref
Crossref
Maurizio Pieroni, Maria De Santis, Gaetano Zizzo, Silvia Bosello, Costantino Smaldone, Mara Campioni, Giacomo De Luca, Antonella Laria, Agostino Meduri, Fulvio Bellocci, Lorenzo Bonomo, Filippo Crea & Gianfranco Ferraccioli. (2014) Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression. Seminars in Arthritis and Rheumatism 43:4, pages 526-535.
Crossref
Crossref
Serdar Soydinc, Ibrahim Halil Turkbeyler, Yavuz Pehlivan, Gulcimen Soylu, Mehmet Fatih Goktepe, Muhammed Bilici, Orhan Zengin, Bunyamin Kisacik & Ahmet Mesut Onat. (2013) Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis. Inflammation 37:1, pages 100-106.
Crossref
Crossref
Paola Gargiulo, Fabio Marsico, Antonio Parente, Stefania Paolillo, Milena Cecere, Laura Casaretti, Angela Maria Pellegrino, Tiziana Formisano, Irma Fabiani, Andrea Soricelli, Bruno Trimarco & Pasquale Perrone-Filardi. (2014) Ischemic heart disease in systemic inflammatory diseases. An appraisal. International Journal of Cardiology 170:3, pages 286-290.
Crossref
Crossref
Nabeel H. Borazan & Daniel E. Furst. 2014. The Autoimmune Diseases. The Autoimmune Diseases
463
480
.
Xiaojing Xing, Ji Yang, Xiaoqin Yang, Yi Wei, Lubing Zhu, Di Gao & Ming Li. (2013) IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway. PLoS ONE 8:12, pages e85032.
Crossref
Crossref
Yongqing Wang & Bashar Kahaleh. (2013) Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma. Journal of Cellular and Molecular Medicine 17:10, pages 1291-1299.
Crossref
Crossref
Lucila Marino Claverie, Elizabeth Knobel, Lorena Takashima, Lorena Techera, Marina Oliver, Paula Gonzalez, Félix E. Romanini, María L. Fonseca & Marta N. Mamani. (2013) Organ involvement in Argentinian systemic sclerosis patients with “late” pattern as compared to patients with “early/active” pattern by nailfold capillaroscopy. Clinical Rheumatology 32:6, pages 839-843.
Crossref
Crossref
Rodrigo Macedo, Marianne Andretta, Carolina Albers, Thelma Skare, Jurandir Marcondes Ribas-Filho & Nicolau Gregori Czeczko. (2012) Avaliação da espessura do complexo médio-intimal da artéria carótida como marcador de aterogênese acelerada secundária a dano vascular na esclerose sistêmica progressiva. Revista do Colégio Brasileiro de Cirurgiões 39:1, pages 10-15.
Crossref
Crossref
Anna Ludwicka-Bradley, Richard M. Silver & Galina S. Bogatkevich. (2011) Coagulation and Autoimmunity in Scleroderma Interstitial Lung Disease. Seminars in Arthritis and Rheumatism 41:2, pages 212-222.
Crossref
Crossref
Uwe-Frithjof Haustein. (2011) Systemic Sclerosis - An Update. Laboratory Medicine 42:9, pages 562-572.
Crossref
Crossref
Zhaodong Li & Sergio A. Jimenez. (2011) Protein kinase Cδ and c‐Abl kinase are required for transforming growth factor β induction of endothelial–mesenchymal transition in vitro. Arthritis & Rheumatism 63:8, pages 2473-2483.
Crossref
Crossref
Mislav Radić, Dušanka Martinović Kaliterna & Josipa Radić. (2011) Helicobacter pylori infection and systemic sclerosis–is there a link?. Joint Bone Spine 78:4, pages 337-340.
Crossref
Crossref
Maurizio Cusmà PiccioneGianluca Bagnato, Concetta Zito, Gianluca Di Bella, Annalisa Caliri, Mariarita Catalano, Caterina Longordo, Giuseppe Oreto, Gianfilippo Bagnato & Scipione Carerj. (2011) Early Identification of Vascular Damage in Patients With Systemic Sclerosis. Angiology 62:4, pages 338-343.
Crossref
Crossref
Nicole Fett & Victoria P. Werth. (2011) Update on morphea. Journal of the American Academy of Dermatology 64:2, pages 217-228.
Crossref
Crossref
Gene-Siew Ngian, Joanne Sahhar, Ian P Wicks & Sharon Van Doornum. (2011) Cardiovascular disease in systemic sclerosis - an emerging association?. Arthritis Research & Therapy 13:4, pages 237.
Crossref
Crossref
M. E. Hettema, H. Bootsma, R. Graaff, R. de Vries, C. G. M. Kallenberg & A. J. Smit. (2011) Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis. International Journal of Rheumatology 2011, pages 1-6.
Crossref
Crossref
Marc Iglarz & Martine Clozel. (2010) At the heart of tissue: endothelin system and end-organ damage. Clinical Science 119:11, pages 453-463.
Crossref
Crossref
Cinzia Scambi, Valentina La Verde, Lucia De Franceschi, Giovanni Barausse, Fabio Poli, Fabio Benedetti, Marco Sorio, Francesca Deriu, Paola Roncada, Oscar Bortolami, Francesco Turrini, Paola Caramaschi, Chiara Stranieri, Lisa M. Bambara & Domenico Biasi. (2010) Comparative Proteomic Analysis of Serum from Patients with Systemic Sclerosis and Sclerodermatous GVHD. Evidence of Defective Function of Factor H. PLoS ONE 5:8, pages e12162.
Crossref
Crossref
G. Castellino, F. Corallini, A. Bortoluzzi, R. L. Corte, A. L. Monaco, P. Secchiero, G. Zauli & F. Trotta. (2010) The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker?. Rheumatology 49:6, pages 1173-1176.
Crossref
Crossref
Taraneh Mehrani & Michelle Petri. 2010. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
645
656
.
S. Hisamori, S. Nagayama, S. Kita, J.-i. Kawamura, A. Yoshizawa & Y. Sakai. (2009) Rapid Progression of Submucosal Invasive Micropapillary Carcinoma of the Colon in Progressive Systemic Sclerosis: Report of a Case. Japanese Journal of Clinical Oncology 39:6, pages 399-405.
Crossref
Crossref
Fredrick M. Wigley. (2008) Vascular Disease in Scleroderma. Clinical Reviews in Allergy & Immunology 36:2-3, pages 150-175.
Crossref
Crossref
Amélie Servettaz, Claire Goulvestre, Niloufar Kavian, Carole Nicco, Philippe Guilpain, Christiane Chéreau, Vincent Vuiblet, Loïc Guillevin, Luc Mouthon, Bernard Weill & Frédéric Batteux. (2009) Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse. The Journal of Immunology 182:9, pages 5855-5864.
Crossref
Crossref
Emmanuelle Tenório Albuquerque Madruga Godoi, Alexandre Domingues Barbosa, Juannicelle Tenório Albuquerque Madruga Godoi, Mariana Atanásio Morais Ramos, Jocelene Tenório Albuquerque Madruga Godoi, Silvio Romero de Barros Marques & Ângela Luzia Branco Pinto Duarte. (2009) Envolvimento macrovascular e esclerose sistêmica. Jornal Vascular Brasileiro 8:1, pages 65-76.
Crossref
Crossref
Alma Cypienė, Aleksandras Laucevicius, Algirdas Venalis, Jolanta Dadonienė, Ligita Ryliskytė, Zaneta Petrulionienė, Milda Kovaitė & Jonas Gintautas. (2008) The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clinical Rheumatology 27:12, pages 1517-1522.
Crossref
Crossref
Y. Stephanie Gu, James Kong, Gurtej S. Cheema, Carl L. Keen, Georg Wick & M. Eric Gershwin. (2008) The Immunobiology of Systemic Sclerosis. Seminars in Arthritis and Rheumatism 38:2, pages 132-160.
Crossref
Crossref
M. E. Hettema, D. Zhang, Y. Stienstra, P. N. H. Oomen, A. J. Smit, C. G. M. Kallenberg & H. Bootsma. (2008) Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankle. Rheumatology 47:9, pages 1409-1412.
Crossref
Crossref
Valeria Riccieri, Antonio Spadaro, Leos Fuksa, Omidreza Firuzi, Luciano Saso & Guido Valesini. (2007) Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis. Clinical Rheumatology 27:2, pages 225-230.
Crossref
Crossref
Daryll M. Baker & Christopher Denton. 2008. Vascular Complications in Human Disease. Vascular Complications in Human Disease
119
127
.
ANNA ABOU‐RAYA, SUZAN ABOU‐RAYA & MADIHAH HELMII. (2007) Statins as Immunomodulators in Systemic Sclerosis. Annals of the New York Academy of Sciences 1110:1, pages 670-680.
Crossref
Crossref
Mizuho Kimura, Yutaka Kawahito, Masahide Hamaguchi, Takashi Nakamura, Masayuki Okamoto, Yukiharu Matsumoto, Hirahito Endo, Aihiro Yamamoto, Hidetaka Ishino, Makoto Wada, Atsushi Omoto, Yasunori Tsubouchi, Masataka Kohno & Toshikazu Yoshikawa. (2007) SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice. Biomedicine & Pharmacotherapy 61:4, pages 222-228.
Crossref
Crossref
Lixin Zhou, David Askew, Caiyun Wu & Anita C. Gilliam. (2007) Cutaneous Gene Expression by DNA Microarray in Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma. Journal of Investigative Dermatology 127:2, pages 281-292.
Crossref
Crossref
Virginia D. Steen. 2007. The Kidney in Systemic Autoimmune Diseases. The Kidney in Systemic Autoimmune Diseases
363
381
.
Graciela S. Alarcón. (2006) Infections in Systemic Connective Tissue Diseases: Systemic Lupus Erythematosus, Scleroderma, and Polymyositis/Dermatomyositis. Infectious Disease Clinics of North America 20:4, pages 849-875.
Crossref
Crossref
A. Santaniello, G. Salazar, S. Lenna, R. Antonioli, G. Colombo, L. Beretta & R. Scorza. (2006) HLA‐B35 upregulates the production of endothelin‐1 in HLA‐transfected cells: a possible pathogenetic role in pulmonary hypertension. Tissue Antigens 68:3, pages 239-244.
Crossref
Crossref
Laura K. Hummers. (2006) Microvascular damage in systemic sclerosis: Detection and monitoring with biomarkers. Current Rheumatology Reports 8:2, pages 131-137.
Crossref
Crossref
Tsutomu Ohtsuka & Soji Yamazaki. (2004) Prevalence of human cytomegalovirus DNA in scleroderma skin tissue. International Journal of Dermatology 45:1, pages 86-87.
Crossref
Crossref
Pierre Quartier & Anne-Marie Prieur. (2006) Maladies inflammatoires du collagène chez l'enfant. EMC - Pédiatrie - Maladies infectieuses 1:1, pages 1-14.
Crossref
Crossref
Xialin Liu, Shoukang Zhu, Tao Wang, Laura Hummers, Fredrick M Wigley, Pascal J Goldschmidt-Clermont & Chunming Dong. (2005) Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice. PLoS Medicine 2:12, pages e354.
Crossref
Crossref
David J. Abraham & John Varga. (2005) Scleroderma: from cell and molecular mechanisms to disease models. Trends in Immunology 26:11, pages 587-595.
Crossref
Crossref
Lorenzo Beretta, Monica Caronni & Raffaella Scorza. (2004) Systemic sclerosis following oral contraception. Clinical Rheumatology 24:3, pages 316-317.
Crossref
Crossref
A. L. Herrick. (2005) Pathogenesis of Raynaud's phenomenon. Rheumatology 44:5, pages 587-596.
Crossref
Crossref
S. Jimnez Hernndez, S. Aguil Mir, G. Delgado Moreno & J. Font Franco. (2005) Esclerosis sist?mica. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:30, pages 1953-1964.
Crossref
Crossref
MICHAEL P. COLLINS & JOHN T. KISSEL. 2005. Peripheral Neuropathy. Peripheral Neuropathy
2335
2404
.
Melanie C. Ruzek, Sharda Jha, Steve Ledbetter, Susan M. Richards & Richard D. Garman. (2004) A modified model of graft‐versus‐host–induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis & Rheumatism 50:4, pages 1319-1331.
Crossref
Crossref
Janusz Prokop & Paweł P. Jagodzinski. (2004) Identification of retroviral conserved pol sequences in serum of mixed connective tissue disease and systemic sclerosis patients. Biomedicine & Pharmacotherapy 58:1, pages 61-64.
Crossref
Crossref
Danielle B. Ulanet, Nicholas A. Flavahan, Livia Casciola‐Rosen & Antony Rosen. (2004) Selective cleavage of nucleolar autoantigen B23 by granzyme B in differentiated vascular smooth muscle cells: Insights into the association of specific autoantibodies with distinct disease phenotypes. Arthritis & Rheumatism 50:1, pages 233-241.
Crossref
Crossref
Cynthia M. Magro, Patrick Ross Jr.Moira Kelsey, W. James Waldman & Amy Pope‐Harman. (2003) Association of Humoral Immunity and Bronchiolitis Obliterans Syndrome. American Journal of Transplantation 3:9, pages 1155-1166.
Crossref
Crossref
Aviv Barzilai, Anna Lyakhovitsky, Ada Horowitz & Henri Trau. (2003) Keloid-like Scleroderma. The American Journal of Dermatopathology 25:4, pages 327-330.
Crossref
Crossref
Claus J. Gruss, Kapaettu Satyamoorthy, Carola Berking, John Lininger, Mark Nesbit, Helmut Schaider, Zhao-June Liu, Masahiro Oka, Mei-Yu Hsu, Takashi Shirakawa, Gang Li, Thomas Bogenrieder, Peter Carmeliet, Wafik S. El-Deiry, Stephen L. Eck, Justi S. Rao, Andrew H. Baker, Jean T. Bennet, Timothy M. Crombleholme, Omaida Velazquez, Jagajan Karmacharya, David J. Margolis, James M. Wilson, Michael Detmar, Mihaela Skobe, Paul D. Robbins, Clayton Buck & Meenhard Herlyn. (2003) Stroma Formation and Angiogenesis by Overexpression of Growth Factors, Cytokines, and Proteolytic Enzymes in Human Skin Grafted to SCID Mice. Journal of Investigative Dermatology 120:4, pages 683-692.
Crossref
Crossref
Marcela Juárez, Richard Misischia & Graciela S Alarcón. (2003) Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheumatic Disease Clinics of North America 29:1, pages 163-184.
Crossref
Crossref
A.D. Blann, J. Constans, P. Carpentier, M. Renard, B. Satger, V. Guérin, M.R. Boisseau, N. Neau-Cransac & C. Conri. (2003) Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease. Thrombosis Research 109:4, pages 203-206.
Crossref
Crossref
P. Quartier & A.M. Prieur. (2003) Enfermedades inflamatorias del colágeno en el niño. EMC - Pediatría 38:4, pages 1-13.
Crossref
Crossref
Damir Hamamdzic, Laura M. Kasman & E. Carwile LeRoy. (2002) The role of infectious agents in the pathogenesis of systemic sclerosis. Current Opinion in Rheumatology 14:6, pages 694-698.
Crossref
Crossref
Lionel Schachna & Fredrick M. Wigley. (2002) Targeting mediators of vascular injury in scleroderma. Current Opinion in Rheumatology 14:6, pages 686-693.
Crossref
Crossref
RAFFAELLA SCORZA, MONICA CARONNI, SONIA BAZZI, FILIPPO NADOR, LORENZO BERETTA, RITA ANTONIOLI, LAURA ORIGGI, ALESSANDRA PONTI, MAURIZIO MARCHINI & MASSIMO VANOLI. (2006) Post‐Menopause is the Main Risk Factor for Developing Isolated Pulmonary Hypertension in Systemic Sclerosis. Annals of the New York Academy of Sciences 966:1, pages 238-246.
Crossref
Crossref
Nicoletta Ronda, Rita Gatti, Roberto Giacosa, Elena Raschi, Cinzia Testoni, Pier Luigi Meroni, Carlo Buzio & Guido Orlandini. (2002) Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin‐linked pathway. Arthritis & Rheumatism 46:6, pages 1595-1601.
Crossref
Crossref
Damir Hamamdzic, Russell A Harley, Debra Hazen-Martin & E Carwile LeRoy. (2001) MCMV induces neointima in IFN-γR-/- mice: Intimal cell apoptosis and persistent proliferation of myofibroblasts. BMC Musculoskeletal Disorders 2:1.
Crossref
Crossref
Larry P. Frohman. (2001) Systemic Disease and Neuro-Ophthalmology: Annual Update 2000 (Part II). Journal of Neuro-Ophthalmology 21:2, pages 74-82.
Crossref
Crossref
Mar�a Galindo, Bego�a Santiago, Miguel Rivero, Joaqu�n Rullas, Jos� Alcami & Jos� Luis Pablos. (2001) Chemokine expression by systemic sclerosis fibroblasts: Abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis & Rheumatism 44:6, pages 1382-1386.
Crossref
Crossref
Christopher P. Denton, Bing Zheng, Xu Shiwen, Zhaoping Zhang, George Bou-Gharios, Heidi Eberspaecher, Carol M. Black & Benoit De Crombrugghe. (2001) Activation of a fibroblast-specific enhancer of the Pro?2(I) collagen gene in tight-skin mice. Arthritis & Rheumatism 44:3, pages 712-722.
Crossref
Crossref
Ariane L Herrick. (2000) Vascular function in systemic sclerosis. Current Opinion in Rheumatology 12:6, pages 527-533.
Crossref
Crossref